Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site’s displayed release/revision version number was incremented from v3.5.2 to v3.5.3, indicating an internal platform update rather than a change to the study record.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed. This is a minor maintenance update that does not change study information.SummaryDifference0.0%

- Check87 days agoChange DetectedNew revision tag v3.4.2 appears and the site-wide funding notice was removed; no trial data or user actions were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check94 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operations. Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.